Endometrial Cancer: State-of-the-Art and Clinical Perspective
Deadline for manuscript submissions: 25 February 2024 | Viewed by 1396
Endometrial carcinoma is the most common gynecologic malignancy, and the incidence of endometrial carcinoma is estimated to increase by 1–2% every year. Treatment modalities in endometrial cancer vary depending on the grade and the stage of the disease. In recent years, sentinel lymph node (SLN) sampling has been advocated as an alternative to standard hysterectomy with complete lymphadenectomy. Surgery is the standard treatment for early-stage endometrial cancer. Additional treatment, depending on the stage of the disease, may include radiation with or without chemotherapy, hormone therapy, immunotherapy, and some targeted therapies. Several new treatments for advanced disease have become available. Determining the molecular subtypes of cancers and deciding treatment according to type have both impacted practice. Other advances in this field include the use of immunotherapy and targeted therapies. This Special Issue aims to report the last advancements regarding the current understanding of endometrial cancer, including genetic background, molecular targeting, surgical management, and adjuvant treatment.
Dr. Francesco Plotti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- endometrial cancer
- sentinel node
- target therapies
- hormone therapy